Immediate Impact

59 standout
Sub-graph 1 of 21

Citing Papers

Plant-Derived Antimicrobials and Their Crucial Role in Combating Antimicrobial Resistance
2024 Standout
ESKAPE pathogens: antimicrobial resistance, epidemiology, clinical impact and therapeutics
2024 Standout
2 intermediate papers

Works of Gina Lin being referenced

Clinical and microbiological outcomes, by causative pathogen, in the ASPECT-NP randomized, controlled, Phase 3 trial comparing ceftolozane/tazobactam and meropenem for treatment of hospital-acquired/ventilator-associated bacterial pneumonia
2021
Ceftolozane–tazobactam versus meropenem for treatment of nosocomial pneumonia (ASPECT-NP): a randomised, controlled, double-blind, phase 3, non-inferiority trial
2019

Author Peers

Author Last Decade Papers Cites
Gina Lin 160 143 102 193 157 10 442
Silvia Boni 106 145 73 203 161 29 458
J.M. Decazes 124 175 49 106 183 23 489
JoCarol McNabb 203 211 77 130 194 13 434
Csaba Fehér 116 155 18 177 187 23 472
Kajal Larson 161 157 16 131 221 24 455
Andrea Parisini 47 144 14 225 179 16 413
Nicole Pagani 100 77 11 209 196 21 406
Elizabeth Castaño 164 76 69 47 177 15 437
Nehama Peled 143 54 8 151 208 18 463
Xavière Panhard 159 30 71 148 130 18 510

All Works

Loading papers...

Rankless by CCL
2026